A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.
FruitiVits
1 other identifier
interventional
11
1 country
1
Brief Summary
Subjects will be asked to substitute their usual vitamin and mineral supplement/s with FruitiVits for seven consecutive days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2014
CompletedFirst Posted
Study publicly available on registry
September 1, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedResults Posted
Study results publicly available
October 7, 2016
CompletedMarch 13, 2024
February 1, 2024
1 month
August 26, 2014
September 7, 2015
February 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Acceptability of FruitiVits
The study product was rated on a scale of 1-5: 1. (liked very much) 2. (liked moderately) 3. (neither liked nor disliked) 4. (disliked moderately) 5. (disliked very much).
Day 8 of trial
Secondary Outcomes (1)
Ease of Preparation of FruitiVits
Day 8 of trial
Study Arms (1)
FruitiVits
EXPERIMENTALDaily administration of FruitiVits dietary supplement
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of condition requiring a Ketogenic diet
- Currently on a Ketogenic diet
- Aged 4 - 8 years
- Routinely taking a complete micronutrient supplement
- Oral feeding
You may not qualify if:
- \) Children aged less than 4 years or older than 9 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vitaflo International, Ltdlead
- Children's Hospital of Philadelphiacollaborator
Study Sites (1)
The Children's Hospital of Philadelphia, Division of Neurology
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Christina Bergqvist, M.D., Study Principal Investigator
- Organization
- The Children's Hospital of Philadelphia
Study Officials
- PRINCIPAL INVESTIGATOR
Christina Bergqvist, M.D
Children's Hospital of Philadelphia
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2014
First Posted
September 1, 2014
Study Start
September 1, 2014
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
March 13, 2024
Results First Posted
October 7, 2016
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share